About John McCabe
John McCabe is an executive officer at Newleos Therapeutics.
John McCabe reports to the SEC as an officer of 2 public companies: Oncorus (ONCR) and Decoy Therapeutics (DCOY).
John McCabe first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name John McCabe in the role, so the role may have started earlier or lasted longer.
OI
Oncorus, Inc.
CFO and Treasurer
2020 – 2022 · Public company (ONCR)
DI
Decoy Therapeutics Inc.
Chief Financial Officer
2015 – 2018 · Public company (DCOY)
Key Colleagues at Startups
The people John McCabe works with at each company, as listed on that company's latest Form D.
Newleos Therapeutics, Inc. · Form D, Feb 24, 2025
DD
David Donabedian
President and CEO, director
RH
Robert Hadfield
Executive officer
CW
Christoph Westphal
Director
MC
Ming Cheah
Director
RC
Raymond Camahort
Director